Hepatitis Testing/Diagnosis Market Drivers, Restraints, Competitive Landscape, Region, End User and Key Players are MedMira Inc., Fujirebio US, Inc., Grifols, S.A., Orasure Technologies

The Hepatitis Testing/Diagnosis Market report encompasses a thorough study of the current situation of the global market along with several market dynamics. To formulate this report, detailed market analysis has been performed with inputs from industry experts. Depending on the client’s demand, a huge amount of business, product, and market-related information has been brought together via this report that eventually helps businesses create better strategies. All of these features are strictly applied while building this Hepatitis Testing/Diagnosis Market research report for a client. It gives an explanation about various definitions and segmentation or classifications of the industry, applications of the industry, and value chain structure.

Get a FREE Sample Copy of this "Hepatitis Testing/Diagnosis Market" Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=1711141

To prepare a market research report, certain steps are to be followed for collecting, recording, and analyzing market data. Hepatitis Testing/Diagnosis Market is a professional and in-depth market report that focuses on primary and secondary drivers, market share, possible sales volume, leading segments, and geographical analysis. Markets at the local, regional and global level are considered in this market document. Businesses can surely go with this report for logical decision making and superior management of marketing of goods and services. Market research reports are very influential in many ways to grow business.

Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026

List of Companies Profiled in the Hepatitis Testing/Diagnosis Market Report

F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott Laboratories (US)
Siemens Healthineers AG (Germany)
Bio-Rad Laboratories, Inc. (US)
Danaher Corporation (US)
QIAGEN (Netherlands)
bioMérieux SA (France)
DiaSorin S.P.A. (Italy)
Ortho Clinical Diagnostics (US)
MedMira Inc. (Canada)
Fujirebio US, Inc. (Japan)
Grifols, S.A. (Spain)
Orasure Technologies (US)
GenMark Diagnostics Inc. (US)
Vela Diagnostics (Singapore)
Epitope Diagnostics (US)
Trivitron Healthcare (India)
Meril Life Sciences Pvt. Ltd. (India)
geneOmbio Technologies Pvt. Ltd. (India)
Molbio Diagnostics Pvt. Ltd. (India)

The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period.

The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis. High cost of nucleic acid tests, lack of mandates for nucleic acid tests in developing countries and unfavorable reimbursement scenarios are expected to restrain hepatitis market growth. Emerging markets, rising technological advancements in molecular diagnostics, and growth in the biotechnology and biopharmaceutical industries are expected to offer strong growth opportunities for players in the market. In contrast, changing regulatory landscape, opertationsla barriers and shortage of skilled professionals may challenge market growth to a certain extent. The hepatitis testing market is segmented based on disease type, technology, end user, and region.

“Hepatitis B segment is expected to dominate the market during the forecast period.”

Based on disease type, the hepatitis testing market is segmented into hepatitis B, hepatitis C, and other hepatitis diseases (hepatitis A, D, and E). The hepatitis B segment accounted for the largest share of the hepatitis testing market in 2020. Factors such as the rising prevalence of hepatitis B, availability of a large number of hepatitis B diagnostic tests, and the increasing adoption of nucleic acid tests for HBV diagnosis are driving the growth of this market segment.

“ELISA segment holds highest market share during the forecast period.”

Based on technology, the hepatitis testing market is segmented into enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), and other technologies (such as sequencing, mass spectrometry, and western blotting). The ELISA segment accounted for the largest share of the hepatitis testing market in 2020. The large share of this segment can primarily be attributed to the wide acceptance of this test in clinical practices to diagnose hepatitis.

“Hospital & Diagnostic Laboratories segment to dominate the market during the forecast period.”

Based on end user, the hepatitis testing market is segmented into hospital & diagnostic laboratories, blood banks, and other end users (academic & government research institutes, nursing homes, and home care settings). In 2020, the hospital & diagnostic laboratories segment accounted for the largest share of the hepatitis testing market. The large share of this segment can be attributed to the large number of hepatitis diagnostic tests carried out in hospitals.

“North America will dominate the market during the forecast period.”

The global hepatitis testing market is segmented into North America (the US and Canada), Europe (Germany, the UK, and the Rest of Europe), Asia Pacific, and Rest of the World. In 2020, North America dominates the global market, and this trend is expected to continue during the forecast period. The large share and high growth of this region can be attributed to the rising prevalence of hepatitis and increased research and clinical trials for hepatitis testing in the US.

The primary interviews conducted for this report can be categorized as follows:

By Company Type -Tier 1: 32%,Tier 2: 42% and Tier 26%
By Designation - C-level:23%, D-level:35%, and Others:42%
By Region - North America:39%, Europe:25%, Asia Pacific:26%, and Rest of the World: 10%

Research Coverage:

This report provides a detailed picture of the global hepatitis testing market. It aims at estimating the size and future growth potential of the market across different segments, such asdisease type, technology, end userand region. The report also analyzes factors (such as drivers, restraints,opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total hepatitis testing market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on hepatitis testing offered by the top 20 players in the hepatitis testing market. The report analyses the hepatitis testing market by disease type, technology, end user and region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hepatitis testing across key geographic regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hepatitis testing market.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the hepatitis testing market.

Purchase this "Hepatitis Testing/Diagnosis Market" report at: https://www.reportsnreports.com/purchase.aspx?name=1711141

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions Of The Study
1.3 Market Scope
Figure 1 Hepatitis Testing Market Segmentation
1.3.1 Years Considered For The Study
1.4 Currency
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 3 Primary Sources
2.1.2.1 Key Industry Insights
Figure 4 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.2 Market Size Estimation
Figure 5 Market Size Estimation: Bottom-Up Approach
2.2.1 Growth Forecast
Figure 6 Cagr Projections: Supply-Side Analysis
Figure 7 Top-Down Approach
2.3 Market Breakdown And Data Triangulation
Figure 8 Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Assumptions For The Study
2.5.1 Covid-19-Specific Assumptions
2.6 Limitations
2.7 Risk Assessment
2.8 Covid-19 Economic Assessment
2.9 Assessment Of The Impact Of Covid-19 On The Economic Scenario
Figure 9 Criteria Impacting The Global Economy
Figure 10 Recovery Scenario Of The Global Economy

3 Executive Summary
Figure 11 Hepatitis Testing Market, By Disease Type, 2021 Vs. 2026 (Usd Million)
Figure 12 Hepatitis Testing Market, By Technology, 2021 Vs. 2026 (Usd Million)
Figure 13 Hepatitis Testing Market, By End User, 2021 Vs. 2026 (Usd Million)
Figure 14 Hepatitis Testing Market, By Region, 2021 Vs. 2026 (Usd Million)

4 Premium Insights
4.1 Hepatitis Testing Market Overview
Figure 15 High Burden Of Hepatitis To Drive Market Growth
4.2 Hepatitis Testing Market, By Technology (2021–2026)
Figure 16 Rapid Diagnostic Tests Segment To Register The Highest Cagr During The Forecast Period
4.3 North America: Hepatitis Testing Market, By Disease Type And Country (2020)
Figure 17 The Us Accounted For The Largest Share Of The North American Hepatitis Testing Market In 2020
4.4 Hepatitis Testing Market: Geographic Growth Opportunities
Figure 18 Asia Pacific To Register The Highest Growth During The Forecast Period

5 Market Overview
5.1 Introduction
Figure 19 Hepatitis Testing Market: Drivers, Restraints, Opportunities, And Challenges
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Burden Of Hepatitis
Table 1 Hepatitis Prevalence, By Region, 2019 (Million)
5.2.1.2 Increasing Blood Transfusion And Donations
Table 2 Average Prevalence Of Hepatitis Infection In Blood Donations, By Income Group
5.2.1.3 Benefits Of Poc Instruments And Kits
5.2.1.4 Awareness Initiatives On Hepatitis
5.2.2 Restraints
5.2.2.1 High Cost Of Nucleic Acid Tests
5.2.2.2 Lack Of Mandates For Nucleic Acid Tests In Developing Countries
5.2.2.3 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Rising Technological Advancements In Molecular Diagnostics
5.2.3.3 Growth In The Biotechnology And Biopharmaceutical Industries
5.2.4 Challenges
5.2.4.1 Changing Regulatory Landscape
5.2.4.2 Operational Barriers
5.2.4.3 Shortage Of Skilled Professionals
5.3 Covid-19 Impact On The Hepatitis Testing Market

6 Hepatitis Testing Market, By Disease Type
6.1 Introduction
Table 3 Hepatitis Testing Market, By Disease Type, 2018–2020 (Usd Million)
Table 4 Hepatitis Testing Market, By Disease Type, 2021–2026 (Usd Million)
6.2 Hepatitis B (Hbv)
6.2.1 Hepatitis B Segment To Hold The Largest Market Share During The Forecast Period
Table 5 Hepatitis B Chronic Infections In The Western Pacific Region, 2019
Table 6 Hepatitis B Testing Market, By Region, 2018–2020 (Usd Million)
Table 7 Hepatitis B Testing Market, By Region, 2021–2026 (Usd Million)
Table 8 North America: Hepatitis B Testing Market, By Country, 2018–2020 (Usd Million)
Table 9 North America: Hepatitis B Testing Market, By Country, 2021–2026 (Usd Million)
Table 10 Europe: Hepatitis B Testing Market, By Country, 2018–2020 (Usd Million)
Table 11 Europe: Hepatitis B Testing Market, By Country, 2021–2026 (Usd Million)
6.3 Hepatitis C (Hcv)
6.3.1 Government Initiatives For Supporting Hcv Diagnosis To Drive Market Growth
Table 12 Hepatitis C Chronic Infections In The Western Pacific Region, 2019
Table 13 Hepatitis C Testing Market, By Region, 2018–2020 (Usd Million)
Table 14 Hepatitis C Testing Market, By Region, 2021–2026 (Usd Million)
Table 15 North America: Hepatitis C Testing Market, By Country, 2018–2020 (Usd Million)
Table 16 North America: Hepatitis C Testing Market, By Country, 2021–2026 (Usd Million)
Table 17 Europe: Hepatitis C Testing Market, By Country, 2018–2020 (Usd Million)
Table 18 Europe: Hepatitis C Testing Market, By Country, 2021–2026 (Usd Million)
6.4 Other Hepatitis Diseases
Table 19 Rep0rted Hepatitis A Cases In The Us Since 2016
Table 20 Other Hepatitis Disease Testing Market, By Region, 2018–2020 (Usd Million)
Table 21 Other Hepatitis Disease Testing Market, By Region, 2021–2026 (Usd Million)
Table 22 North America: Other Hepatitis Disease Testing Market, By Country, 2018–2020 (Usd Million)
Table 23 North America: Other Hepatitis Disease Testing Market, By Country, 2021–2026 (Usd Million)
Table 24 Europe: Other Hepatitis Disease Testing Market, By Country, 2018–2020 (Usd Million)
Table 25 Europe: Other Hepatitis Disease Testing Market, By Country, 2021–2026 (Usd Million)

7 Hepatitis Testing Market, By Technology

Get a Discount on the Latest "Hepatitis Testing/Diagnosis Market" Report at: https://www.reportsnreports.com/contacts/discount.aspx?name=1711141

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.